Updated:
C-Bridge Capital
C-Bridge Capital was founded in 1996 by Gong Chen, a physician-turned-investor who previously led China operations for a U.S.-based healthcare venture...
C-Bridge Capital
C-Bridge Capital was founded in 1996 by Gong Chen, a physician-turned-investor who previously led China operations for a U.S.-based healthcare venture firm. The firm's name reflects its central thesis: connecting U.S. healthcare innovation with China's market scale and manufacturing capability. The firm pursues a hybrid strategy combining growth equity, buyout, and cross-border advisory. Its investment focus spans biopharmaceuticals, medical devices, diagnostics, and healthcare IT. Notable portfolio positions have included WuXi AppTec (a China-based contract research organization), iKang Healthcare Group (a health-checkup chain listed on Nasdaq before being taken private), and Tianjin-based medical device maker NuoBao Medical. Geography is principally U.S. and China, with occasional expansion into other Asian markets. Team size and total AUM are not publicly disclosed. C-Bridge maintains its sole office in Boston, Massachusetts. The firm does not appear to operate a separately branded philanthropic foundation or a multi-family office. A recent operational event: no verifiable public disclosure of a transaction or fundraise in the last 24 months. C-Bridge Capital's structural differentiator is its explicit bridge mandate — most healthcare-focused investment firms operate within a single region. By maintaining operational capability on both sides of the Pacific, C-Bridge positions itself to execute cross-border deals that single-region firms cannot easily replicate. The firm operates as a private investment firm rather than a registered investment adviser.
General information
Firm type
Asset Manager
Year founded
1996
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Boston
Corporate office
Boston, MA, United States
Principals
Gong Chen
Founder and Managing Partner
Sector focus
Frequently asked questions
Who runs investment decisions at C-Bridge Capital?
Gong Chen, founder and managing partner, leads investment decisions. Chen is a medical doctor by training and previously led China operations for a U.S.-based healthcare venture firm before founding C-Bridge in 1996 (per public record).
Is C-Bridge Capital a single family office or an asset manager?
C-Bridge Capital operates as a private asset manager, not a family office. It does not manage capital for a single wealthy family. The firm's legal structure is a limited liability company.
What investment stages does C-Bridge Capital target?
C-Bridge focuses on growth equity and buyout transactions. It invests across the maturity spectrum in healthcare companies, from later-stage venture to established firms requiring expansion capital or cross-border support.
Which sectors does C-Bridge Capital focus on?
The firm is exclusively healthcare-focused, with coverage in life sciences (biotech, pharma), medical devices, diagnostics, healthcare services, and digital health. It does not invest outside healthcare.
How does C-Bridge Capital source proprietary deal flow?
The firm leverages its cross-border positioning and Chen's network built over decades in U.S.-China healthcare. Its deal flow comes from direct relationships with healthcare companies seeking capital and cross-border expertise, rather than through a formal intermediary network.
Does C-Bridge Capital participate in fund commitments or only direct deals?
C-Bridge Capital primarily makes direct investments in companies. It has not been publicly identified as a limited partner in third-party funds. The firm's strategy is to control or co-lead investments rather than commit capital to external managers.
Where does the underlying capital at C-Bridge Capital come from?
The capital sources are not publicly disclosed. As a private firm, C-Bridge does not publish its investor base. The firm likely draws on institutional capital and high-net-worth individuals, but no specific sources have been confirmed.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on registered investment advisers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: